CAS 956483-03-7

Formula: C27H36ClN3O6

InChI: InChI=1S/C27H35N3O6.ClH/c1-4-5-6-7-17-8-10-18(11-9-17)21-12-19-14-30(27(33)29-25(19)36-21)23-13-20(31)22(35-23)15-34-26(32)24(28)16(2)3;/h8-12,14,16,20,22-24,31H,4-7,13,15,28H2,1-3H3;1H/t20-,22+,23+,24-;/m0./s1

InChI key: CAHTYTZOAVUCIU-ZMQZINMSSA-N

SMILES: CCCCCC1=CC=C(C=C1)C2=CC3=CN(C(=O)N=C3O2)[C@H]4C[C@@H]([C@H](O4)COC(=O)[C@H](C(C)C)N)O.Cl

FV-100

CAS: 956483-03-7

FV-100

Formula: C₂₇H₃₆ClN₃O₆

Purity: 98.5%

Molecular weight: 534.04

Ref: 54-BUP11637

FV-100

CAS: 956483-03-7

FV-100 (Valnivudine HCl), API for CF-1743, is a potent, oral anti-vaxx-zoster drug with low in vivo toxicity.

Formula: C₂₇H₃₆ClN₃O₆

Purity: 98.52%

Color and Shape: White Solid

Molecular weight: 534.044

Ref: TM-T41116

(S)-((2R,3S,5R)-3-Hydroxy-5-(2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3(2H)-yl)tetrahydrofuran-2-yl)methyl 2-amino-3-methylbutanoate hydrochloride

CAS: 956483-03-7

(S)-((2R,3S,5R)-3-Hydroxy-5-(2-oxo-6-(4-pentylphenyl)furo[2,3-d]pyrimidin-3(2H)-yl)tetrahydrofuran-2-yl)methyl 2-amino-3-methylbutanoate hydrochloride

Formula: C₂₇H₃₆ClN₃O₆

Purity: 98%

Molecular weight: 534.04

Ref: IN-DG01316850

FV 100-d7 (Major)

Controlled Product

CAS: 956483-02-6, 956483-03-7

Applications FV 100-d7 is labelled FV 100 (F870000), an orally available nucleoside analogue prodrug of CF-1743 (C291710) which is used for the treatment of herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV.
References McGuigan, C., et al.: J. Med. Chem., 43, 4993 (2000); McGuigan, C., et al.: J. Antimicro. Chemother., 60, 1316 (2007); Andrei, G., et al.: Antimicro. Agents Chemother., 49, 1081 (2005)

Formula: C₂₇D₇H₂₈N₃O₆

Color and Shape: Neat

Molecular weight: 504.626

Ref: TR-F870002

FV 100 Hydrochloride

Controlled Product

CAS: 956483-03-7

Formula: C₂₇H₃₅N₃O₆·ClH

Color and Shape: Neat

Molecular weight: 534.044

Ref: TR-F871000

Valnivudine hydrochloride

CAS: 956483-03-7

Valnivudine hydrochloride is an antiviral drug that inhibits the replication of herpes viruses by inhibiting viral DNA polymerase. It is used to treat shingles and post-herpetic neuralgia. Valnivudine hydrochloride has been shown to be effective in reducing the severity and duration of symptoms, as well as reducing significant morbidity, when given to patients with shingles or post-herpetic neuralgia. Valnivudine hydrochloride also has a role in the prevention of transmission of HIV from mother to child during pregnancy, childbirth, and breastfeeding.

Formula: C₂₇H₃₆ClN₃O₆

Purity: Min. 95%

Molecular weight: 534 g/mol

Ref: 3D-FV180234